Godavari Drugs Limited (BOM:530317)
95.41
+7.30 (8.29%)
At close: Jan 22, 2026
Godavari Drugs Market Cap
Godavari Drugs has a market cap or net worth of 718.49 million as of January 23, 2026. Its market cap has decreased by -13.11% in one year.
Market Cap
718.49M
Enterprise Value
1.43B
Revenue
1.06B
Ranking
n/a
PE Ratio
19.40
Stock Price
95.41
Market Cap Chart
Since April 30, 2001, Godavari Drugs's market cap has increased from 15.34M to 718.49M, an increase of 4,582.81%. That is a compound annual growth rate of 16.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 687.01M | 18.74% |
| Dec 31, 2025 | 578.57M | -29.74% |
| Dec 31, 2024 | 823.46M | 21.42% |
| Dec 29, 2023 | 678.20M | -5.10% |
| Dec 30, 2022 | 714.64M | 51.48% |
| Dec 31, 2021 | 471.79M | 79.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mercury Laboratories | 939.60M |
| Source Natural Foods and Herbal Supplements | 901.49M |
| Amwill Health Care | 844.15M |
| Zenith Drugs | 835.15M |
| Phaarmasia | 753.36M |
| Mangalam Drugs & Organics | 741.87M |
| Asston Pharmaceuticals | 725.30M |
| Accretion Pharmaceuticals | 711.98M |